Trial Profile
Combination effects of an angiotensin receptor blocker and an L/T type calcium channel blocker in hypertensive patients with type 2 diabetes mellitus.
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 16 May 2016
Price :
$35
*
At a glance
- Drugs Amlodipine (Primary) ; Benidipine (Primary) ; Angiotensin receptor antagonists
- Indications Essential hypertension
- Focus Therapeutic Use
- Acronyms COEN
- 13 Mar 2012 New trial record